Respiratory failure & ventilation

Effects of a lower versus a higher oxygenation target in intensive care unit patients with chronic obstructive pulmonary disease and acute hypoxaemic respiratory failure: a subgroup analysis of a randomised clinical trial

BJA OpenPublished Secondary analysis of the Handling Oxygenation Targets in the ICU (HOT-ICU) randomised trial

Primary result · Mortality (COPD subgroup)Result — go to the resultRelative risk 0.98 95% CI 0.82–1.17

Authors' conclusion

In ICU patients with COPD and acute hypoxaemia, a lower vs a higher oxygenation target did not reduce mortality.

Study context

Population
Intensive care unit (ICU) patients with chronic obstructive pulmonary disease (COPD) and acute hypoxaemiaCOPD subgroup of 2928
Participants
563 patients
Comparison
Lower vs higher oxygenation target
  • Lowern = 277
  • Highern = 286reference
Primary endpoint
Mortality
Follow-up
Up to 90 days
Methodological detailspre-planned subgroup analysis, stratified allocation
  • Pre-planned subgroup analysis
  • Stratified allocation

Primary result

Mortality (COPD subgroup)

Relative risk

0.98

95% CI 0.82–1.17

P = 0.67

Events by treatment group

Lower vs Higher
RR 0.98 (95% CI 0.82–1.17); P = 0.67

As reported in the abstract

Secondary outcomes

PaO2 after allocation

PaCO2 (time-weighted average)

  • PaCO2 (time-weighted average): data for 497 patients (88%)

PaCO2 (time-weighted average)

No between-group difference

Secondary outcomes

No statistically significant differences in any secondary outcome

Original publication

Effects of a lower versus a higher oxygenation target in intensive care unit patients with chronic obstructive pulmonary disease and acute hypoxaemic respiratory failure: a subgroup analysis of a randomised clinical trial. BJA Open. Published 29 April 2024. doi:10.1016/j.bjao.2024.100281

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.